Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if VYGR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
135 filers reported a long position in VYGR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $18.1M | 5.2M | -7.1% |
| MILLENNIUM MANAGEMENT LLC | $15.6M | 4.4M | +29.6% |
| ARMISTICE CAPITAL, LLC | $12M | 3.4M | -1.8% |
| Vestal Point Capital, LP | $9.2M | 2.6M | -12.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.2M | 2.3M | +2.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $4.7M | 1.3M | +26.7% |
| Opaleye Management Inc. | $4.1M | 1.2M | +3% |
| STATE STREET CORP | $3.8M | 1.1M | +13.5% |
| TWO SIGMA INVESTMENTS, LP | $3.3M | 948.5K | +54.1% |
| DIMENSIONAL FUND ADVISORS LP | $2.9M | 838.2K | -4.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.